It doesn’t constitute noise if you control for males under 40, especially Moderna. Early on this would have potentially just been data mining, but it’s been replicated and has also led to pulling Moderna for those age groups in some countries. 1 in 10k isn’t a massive risk, but when taken in conjunction with the mandates making the population this is administered in to be “all living humans” then the absolute numbers get very concerning imo, esp if you think there may be more subclinical cases than we think.
> if you control for males under 40, especially Moderna
Fascinating! Thanks. (to be pedantic, my emphasis on the word "was", meant to convey that my opinion was changing)
I was gonna ask "do you have a source on that?" but was able to find this in JAMA w/o much effort: https://jamanetwork.com/journals/jama/fullarticle/2788346
which states in no uncertain terms that "The rates of myocarditis cases were... in adolescent males aged 16 to 17 years .. 105.9 per million doses of the BNT162b2 vaccine", sure enough, 1 in ~10k.
I think it's also important to note, just for larger context -- not attacking or negating anything you've said -- that that cohort (16-17yo males) is the most extreme, it's down to 1 in ~20k once you include up to age 24. Across the whole population it becomes closer to 1 in 200k.
